
|Articles|May 1, 2003
Patients taking digoxin may develop color blindness
Author(s)J.G. Lawrenson, PhD, Nancy Groves
London-Routine testing for color vision deficiency is not a reliable method to detect digoxin toxicity in patients taking the drug for heart failure or other cardiac problems, said J.G. Lawrenson, PhD.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Tinlarebant NDA submission completed for Stargardt disease type 1, targeting first approved therapy
2
FDA accepts Outlook Therapeutics' resubmitted BLA for ONS-5010 (LYTENAVA)
3
Study finds mixed real and synthetic eye images enhance ocular AI performance
4
IOLs: What Every Surgeon Needs to Know | Ep. 2: Enhanced monofocal IOLs
5





















